In Big Picture, Familial AD’s Biomarker Data Resemble LOAD
Alzforum.—Esther Landhuis. None http://www.alzforum.org/new/detail.asp?id=3235 Alzheimer's Disease Amyloid
373 RESULTS
You searched Landhuis
Sort By:
Alzforum.—Esther Landhuis. None http://www.alzforum.org/new/detail.asp?id=3235 Alzheimer's Disease Amyloid
approaches, see Part 2. For more detail, see Neuroscience 2009 abstracts.—Esther Landhuis. This is Part 1 of
are the potential side effects?” His lab is working to address these issues.—Esther Landhuis. This is
strength for the duration of the study,” she said.—Esther Landhuis. This is Part 1 of a two-part series.
medical care for older people, Jones noted.—Esther Landhuis. This is a two-part story. See also Part 2.
developments, read Part 2.—Esther Landhuis. This is Part 1 of a four-part series. See also Part 2, Part 3, Part
an effect.”—Esther Landhuis. None http://www.alzforum.org/new/detail.asp?id=2531 Alzheimer's
looking at the ADAS-Cog for 15 years.”—Esther Landhuis. None
and effectively in future trials.”—Esther Landhuis. This is Part 1 of a two-part series. See also Part
FTD phenotype,” Boxer told ARF.—Esther Landhuis. This is Part 2 of a three-part series. See also Part
Landhuis. None http://www.alzforum.org/new/detail.asp?id=3222 Alzheimer's Disease Clinical Research
November 2011 in San Diego.—Esther Landhuis. This concludes a three-part series. See also Part 1 and Part
penetrate the topic of synaptic pathophysiology in neurodegenerative disease.—Esther Landhuis. This